Latest filing published 22 Dec 2022 for Erasca, Inc., €78k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -47.1%Entry US$4.10 · Close at T+365 US$2.17
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James Arthur Bristol: trading record in brief
Filings by James Arthur Bristol span 2 companies, the busiest being Deciphera Pharmaceuticals, Inc. and Erasca, Inc. Between 5 February 2019 and 21 December 2022, the trades on record add up to 54 filings.
In open-market terms, that means 1 purchase worth €78k on one side and 36 sales worth €8.0M on the other. The net balance comes to €7.9M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 17 option exercises. So far in 2022, the count stands at 1 purchase and no sales.
The latest filing, published on 22 December 2022, reports an open-market purchase of €78k in Erasca, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James Arthur Bristol
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$4.14100.0% of flowCommon StockSEC:0001209191-22-062536:0Canonical exit: 21 Mar 2023 (T+90)
- 5,300 shares@ US$3.950.2% of flowCommon StockSEC:0001209191-21-027789:0
- 4,000 shares@ US$46.131.8% of flowCommon StockSEC:0001209191-21-027789:1
- 1,300 shares@ US$46.660.6% of flowCommon StockSEC:0001209191-21-027789:2
- 1,700 shares@ US$3.950.1% of flowCommon StockSEC:0001209191-21-027789:3
- 1,700 shares@ US$45.600.8% of flowCommon StockSEC:0001209191-21-027789:4
- 14,700 shares@ US$3.950.6% of flowCommon StockSEC:0001209191-21-026633:0
- 9,483 shares@ US$43.704.2% of flowCommon StockSEC:0001209191-21-026633:1
- 5,217 shares@ US$44.092.3% of flowCommon StockSEC:0001209191-21-026633:2
- 7,000 shares@ US$3.950.3% of flowCommon StockSEC:0001209191-21-004246:0
- 6,400 shares@ US$50.213.2% of flowCommon StockSEC:0001209191-21-004246:1
- 600 shares@ US$51.110.3% of flowCommon StockSEC:0001209191-21-004246:2
- 23,541 shares@ US$1.890.8% of flowCommon StockSEC:0001209191-20-054633:0
- 19,370 shares@ US$53.353219.4% of flowCommon StockSEC:0001209191-20-054633:1
- 3,971 shares@ US$54.52814.1% of flowCommon StockSEC:0001209191-20-054633:2
- 200 shares@ US$55.430.2% of flowCommon StockSEC:0001209191-20-054633:3
- 16,324 shares@ US$1.890.5% of flowCommon StockSEC:0001209191-20-042243:0
- 7,217 shares@ US$1.890.2% of flowCommon StockSEC:0001209191-20-042243:1
- 12,361 shares@ US$54.6510.7% of flowCommon StockSEC:0001209191-20-042243:2
- 9,050 shares@ US$55.157.9% of flowCommon StockSEC:0001209191-20-042243:3
- 1,829 shares@ US$56.241.6% of flowCommon StockSEC:0001209191-20-042243:4
- 301 shares@ US$57.020.3% of flowCommon StockSEC:0001209191-20-042243:5
- 23,542 shares@ US$1.890.6% of flowCommon StockSEC:0001209191-20-024252:0
- 6,373 shares@ US$42.973.8% of flowCommon StockSEC:0001209191-20-024252:1
- 5,621 shares@ US$43.933.5% of flowCommon StockSEC:0001209191-20-024252:2
25 of 54 declarations
